Patents by Inventor Ralph C. Judd

Ralph C. Judd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OMP85 Proteins of Neisseria Gonorrhoeae and Neisseria Meningitidis, Compositions Containing Same and Methods of Use Thereof
    Publication number: 20100272744
    Abstract: Nucleic acid and amino acid sequences of the Omp85 proteins of N. gonorrhoeae and N. meningitidis, and fragments thereof are useful in vaccine compositions, therapeutic compositions and diagnostic compositions for use in the prevention, treatment and diagnosis of non-symptomatic gonococcal infection or symptomatic disease and non-symptomatic meningococcal infection and symptomatic disease. Antibodies are developed to these proteins and also useful in the compositions and methods described herein.
    Type: Application
    Filed: April 9, 2010
    Publication date: October 28, 2010
    Applicant: THE UNIVERSITY OF MONTANA
    Inventors: RALPH C. JUDD, D. SCOTT MANNING
  • Omp85 proteins of and , compositions containing same and methods of use thereof
    Patent number: 7794733
    Abstract: Nucleic acid and amino acid sequences of the Omp85 proteins of N. gonorrhoeae and N. meningitidis, and fragments thereof are useful in vaccine compositions, therapeutic compositions and diagnostic compositions for use in the prevention, treatment and diagnosis of non-symptomatic gonococcal infection or symptomatic disease and non-symptomatic meningococcal infection and symptomatic disease. Antibodies are developed to these proteins and also useful in the compositions and methods described herein.
    Type: Grant
    Filed: June 26, 2003
    Date of Patent: September 14, 2010
    Assignee: The University of Montana
    Inventors: Ralph C. Judd, D. Scott Manning
  • Omp85 proteins of and , compositions containing same and methods of use thereof
    Patent number: 7662588
    Abstract: Nucleic acid and amino acid sequences of the Omp85 proteins of N. gonorrhoeae and N. meningitidis, and fragments thereof are useful in vaccine compositions, therapeutic compositions and diagnostic compositions for use in the prevention, treatment and diagnosis of non-symptomatic gonococcal infection or symptomatic disease and non-symptomatic meningococcal infection and symptomatic disease. Antibodies are developed to these proteins and also useful in the compositions and methods described herein.
    Type: Grant
    Filed: November 29, 2006
    Date of Patent: February 16, 2010
    Assignee: The University of Montana
    Inventors: Ralph C. Judd, D. Scott Manning
  • OMP85 protein of neisseria meningitidis, compositions containing the same and methods of use thereof
    Patent number: 6610306
    Abstract: Nucleic acid and amino acid sequences of the Omp85 proteins of N. gonorrhoeae and N. meningitidis, and fragments thereof are useful in vaccine compositions, therapeutic compositions and diagnostic compositions for use in the prevention, treatment and diagnosis of non-symptomatic gonococcal infection or symptomatic disease and non-symptomatic meningococcal infection and symptomatic disease. Antibodies are developed to these proteins and also useful in the compositions and methods described herein.
    Type: Grant
    Filed: November 26, 2001
    Date of Patent: August 26, 2003
    Assignee: The University of Montana
    Inventors: Ralph C. Judd, D. Scott Manning
  • Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof
    Publication number: 20020086028
    Abstract: Nucleic acid and amino acid sequences of the Omp85 proteins of N. gonorrhoeae and N. meningitidis, and fragments thereof are useful in vaccine compositions, therapeutic compositions and diagnostic compositions for use in the prevention, treatment and diagnosis of non-symptomatic gonococcal infection or symptomatic disease and non-symptomatic meningococcal infection and symptomatic disease. Antibodies are developed to these proteins and also useful in the compositions and methods described herein.
    Type: Application
    Filed: November 26, 2001
    Publication date: July 4, 2002
    Inventors: Ralph C. Judd, D. Scott Manning